The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 756K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

12 articles for E Carosati


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Understanding Oxadiazolothiazinone Biological Properties: Negative Inotropic Activity versus Cytochrome P450-Mediated Metabolism.EBI
University of Perugia
Comparison of ligand-based and structure-based 3D-QSAR approaches: a case study on (aryl-)bridged 2-aminobenzonitriles inhibiting HIV-1 reverse transcriptase.EBI
University of Perugia
Inhibitor of ovarian cancer cells growth by virtual screening: a new thiazole derivative targeting human thymidylate synthase.EBI
University of Perugia
Pyrazolo[4,3-c][1,2]benzothiazines 5,5-dioxide: a promising new class of Staphylococcus aureus NorA efflux pump inhibitors.EBI
University of Perugia
A novel approach for predicting P-glycoprotein (ABCB1) inhibition using molecular interaction fields.EBI
University of Perugia
Ligand-based virtual screening and ADME-tox guided approach to identify triazolo-quinoxalines as folate cycle inhibitors.EBI
Università
Virtual screening for novel openers of pancreatic K(ATP) channels.EBI
University of Perugia
Stereoselective behavior of the functional diltiazem analogue 1-[(4-chlorophenyl)sulfonyl]-2-(2-thienyl)pyrrolidine, a new L-type calcium channel blocker.EBI
Universita Degli Studi Di Perugia
L-Type calcium channel blockers: from diltiazem to 1,2,4-oxadiazol-5-ones via thiazinooxadiazol-3-one derivatives.EBI
Universita Degli Studi Di Bologna
Discovery of novel and cardioselective diltiazem-like calcium channel blockers via virtual screening.EBI
University of Perugia
Calcium channel antagonists discovered by a multidisciplinary approach.EBI
University of Perugia
Side-Chain Modified Ergosterol and Stigmasterol Derivatives as Liver X Receptor Agonists.EBI
University of Perugia